183 related articles for article (PubMed ID: 30831307)
1. PHARMECMO: Therapeutic drug monitoring and adequacy of current dosing regimens of antibiotics in patients on Extracorporeal Life Support.
Bouglé A; Dujardin O; Lepère V; Ait Hamou N; Vidal C; Lebreton G; Salem JE; El-Helali N; Petijean G; Amour J
Anaesth Crit Care Pain Med; 2019 Oct; 38(5):493-497. PubMed ID: 30831307
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic therapeutic drug monitoring in intensive care patients treated with different modalities of extracorporeal membrane oxygenation (ECMO) and renal replacement therapy: a prospective, observational single-center study.
Kühn D; Metz C; Seiler F; Wehrfritz H; Roth S; Alqudrah M; Becker A; Bracht H; Wagenpfeil S; Hoffmann M; Bals R; Hübner U; Geisel J; Lepper PM; Becker SL
Crit Care; 2020 Nov; 24(1):664. PubMed ID: 33239110
[TBL] [Abstract][Full Text] [Related]
3. OTAC: Optimization of Antibiotic Therapy in Critically ill Patients. Using beta-lactam antibiotics by continuous infusion.
Esteve-Pitarch E; Padullés-Zamora A; Maisterra-Santos K; Colom-Codina H; Cobo-Sacristán S
Farm Hosp; 2019 Sep; 43(5):151-157. PubMed ID: 31469627
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics of cefepime in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study).
Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Corley A; Diehl A; Jakob SM; Levkovich BJ; Pellegrino V; Que YA; Reynolds C; Rudham S; Wallis SC; Welch SA; Zacharias D; Roberts JA; Shekar K; Fraser JF
Int J Antimicrob Agents; 2021 Dec; 58(6):106466. PubMed ID: 34688834
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of therapeutic drug monitoring of piperacillin and meropenem in routine clinical practice: a prospective cohort study in critically ill patients.
Schoenenberger-Arnaiz JA; Ahmad-Diaz F; Miralbes-Torner M; Aragones-Eroles A; Cano-Marron M; Palomar-Martinez M
Eur J Hosp Pharm; 2020 Mar; 27(e1):e30-e35. PubMed ID: 32296502
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacokinetics and pharmacodynamics of antibiotics in septic children treated with extracorporeal membrane oxygenation].
Zhang HX; Huang JT; Dong J; Gong TZ; Zhang KY; Lu XL; Guo SW
Zhonghua Er Ke Za Zhi; 2023 Jul; 61(7):631-636. PubMed ID: 37385807
[No Abstract] [Full Text] [Related]
7. Extended-Interval Dosing of Gentamicin Aiming for a Drug-Free Period in Neonates: A Prospective Cohort Study.
van Maarseveen EM; Sprij A; Touw DJ
Ther Drug Monit; 2016 Jun; 38(3):402-6. PubMed ID: 26836810
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients.
Hahn J; Choi JH; Chang MJ
J Clin Pharm Ther; 2017 Dec; 42(6):661-671. PubMed ID: 28948652
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial.
Hagel S; Fiedler S; Hohn A; Brinkmann A; Frey OR; Hoyer H; Schlattmann P; Kiehntopf M; Roberts JA; Pletz MW;
Trials; 2019 Jun; 20(1):330. PubMed ID: 31171029
[TBL] [Abstract][Full Text] [Related]
10. Predictors of insufficient peak amikacin concentration in critically ill patients on extracorporeal membrane oxygenation.
Touchard C; Aubry A; Eloy P; Bréchot N; Lebreton G; Franchineau G; Besset S; Hékimian G; Nieszkowska A; Leprince P; Luyt CE; Combes A; Schmidt M
Crit Care; 2018 Aug; 22(1):199. PubMed ID: 30121083
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of meropenem in children with sepsis undergoing extracorporeal life support: A prospective observational study.
Wang Y; Li Z; Chen W; Yan G; Wang G; Lu G; Chen C
J Clin Pharm Ther; 2021 Jun; 46(3):754-761. PubMed ID: 33476064
[TBL] [Abstract][Full Text] [Related]
12. [Plasmatic concentracion of piperacillin/tazobactam in pediatric patients on ECMO support. Preliminary analysis].
Zylbersztajn B; Izquierdo C G; Navea M D; Torres T JP; Valverde G C
Rev Chilena Infectol; 2020 Jun; 37(3):216-218. PubMed ID: 32853311
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic drug monitoring of amikacin in septic patients.
Duszynska W; Taccone FS; Hurkacz M; Kowalska-Krochmal B; Wiela-Hojeńska A; Kübler A
Crit Care; 2013 Jul; 17(4):R165. PubMed ID: 23886243
[TBL] [Abstract][Full Text] [Related]
14. β-Lactam pharmacokinetics during extracorporeal membrane oxygenation therapy: A case-control study.
Donadello K; Antonucci E; Cristallini S; Roberts JA; Beumier M; Scolletta S; Jacobs F; Rondelet B; de Backer D; Vincent JL; Taccone FS
Int J Antimicrob Agents; 2015 Mar; 45(3):278-82. PubMed ID: 25542059
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacologic studies or aminoglycoside antibiotics (amikacin, gentamicin, sisomicin, tobramycin)].
Lode H; Grunert K; Kemmerich B; Koeppe P
Adv Clin Pharmacol; 1978; 15():35-44. PubMed ID: 676877
[TBL] [Abstract][Full Text] [Related]
16. Impact of extracorporeal membrane oxygenation (ECMO) support on piperacillin exposure in septic patients: a case-control study.
Fillâtre P; Lemaitre F; Nesseler N; Schmidt M; Besset S; Launey Y; Maamar A; Daufresne P; Flecher E; Le Tulzo Y; Tadie JM; Tattevin P
J Antimicrob Chemother; 2021 Apr; 76(5):1242-1249. PubMed ID: 33569597
[TBL] [Abstract][Full Text] [Related]
17. Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?
Roberts JA; Roberts MS; Robertson TA; Dalley AJ; Lipman J
Crit Care Med; 2009 Mar; 37(3):926-33. PubMed ID: 19237898
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a retrospective analysis of four years of clinical experience.
Richter DC; Frey O; Röhr A; Roberts JA; Köberer A; Fuchs T; Papadimas N; Heinzel-Gutenbrunner M; Brenner T; Lichtenstern C; Weigand MA; Brinkmann A
Infection; 2019 Dec; 47(6):1001-1011. PubMed ID: 31473974
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of pharmacokinetic/pharmacodynamic and clinical outcomes with 6-hourly empiric piperacillin-tazobactam dosing in hematological malignancy patients with febrile neutropenia.
Weber N; Jackson K; McWhinney B; Ungerer J; Kennedy G; Lipman J; Roberts JA
J Infect Chemother; 2019 Jul; 25(7):503-508. PubMed ID: 30879981
[TBL] [Abstract][Full Text] [Related]
20. Interest of therapeutic drug monitoring of aminoglycosides administered by a monodose regimen.
Ben Romdhane H; Ben Fredj N; Chaabane A; Ben Aicha S; Chadly Z; Ben Fadhel N; Boughattas N; Aouam K
Nephrol Ther; 2019 Apr; 15(2):110-114. PubMed ID: 30660586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
